table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 prophylaxis (excluding children)
anti-inflammatoty and immuno-therapy
anti-inflammatory therapies
colchicine Gendelman
non-steroidal anti-inflammatory drugs Chandan
Immunostimulants drugs
neutralizing antibody
bamlanivimab monotherapy BLAZE-2 US ...
casirivimab/imdevimab (Ronapreve) Cov-2069 ...
cilgavimab and tixagevimab (Evusheld) PROVENT Jurdi

3 studies excluded by filtering options 2

4930 Huijie Bian, 2020 2313excludednot a RCThigh risk of bias
5612 Bernaola, 2020 2130excludednot a RCTrisk of bias not avaialble
8158 Yildiz, 2021 210excludedrisk of bias not avaialble

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons